Skip to main content

Table 3 The immunohistochemical features and EBV status of 28 patients with CD20-neagtive diffuse large B-cell lymphoma

From: CD20-negative de novo diffuse large B-cell lymphoma in HIV-negative patients: A matched case-control analysis in a single institution

Patient NO.

Age, y/Sex

Sampling Site

CD45

CD20

CD79a

CD5

CD3

BCL-2

CD10

BCL-6

Mum-1

Ki-67 (%)

EBER ISH

1

68/M

LN

+

-

+

-

-

-

-

NT

+

90

-

2

33/F

Cevical

+

-

NT

NT

NT

NT

NT

NT

NT

NT

NT

3

49/F

Maxillary Sinus

+

-†

+

NT

-

NT

NT

NT

NT

NT

NT

4

11/M

Spinal canal

+

-

+

-

-

+

-

-

+

80

-

5

37/M

Retroperitoneal

+

-

+

-

-

-

NT

NT

NT

80

-

6

56/M

Retroperitoneal

+

-

+

-

-

+

-

-

NT

90

-

7

54/F

Stomach

+

-

+

-

-

-

-

-

+

80

-

8

73/M

LN

+

-

+

-

-

-

-

-

+

80

+

9

44/M

LN

+

-

+

-

-

NT

-

-

+

90

NT

10

41/M

Stomach

+

-

+

NT

-

NT

NT

NT

NT

NT

NT

11

66/M

Stomach

+

-

+

-

-

NT

-

-

-

80

-

12

22/M

Hip

+

-

+

NT

-

NT

NT

NT

-

NT

NT

13

55/M

LN

NT

-

-

-

-

NT

-

NT

+

70

-

14

19/F

Stomach

+

-

+

-

-

+

-

NT

+

90

-

15

67/M

LN

+

- ‡

+

-

-

-

-

-

+

70

-

16

47/F

Liver

+

-

+

-

-

+

-

-

+

90

-

17

27/M

Pleural

+

-

+

-

NT

+

-

-

+

60

-

18

83/M

LN

+

-

+

-

-

+

+

+

+

100

NT

19

53/M

Stomach

+

-§

+

-

-

+

+

NT

+

100

-

20

67/M

LN

+

-¶

+

-

-

+

-

+

+

90

-

21

71/M

Sternum

+

-

+

-

-

NT

+

NT

NT

90

-

22

62/F

LN

+

-

+

-

-

+

+

NT

+

80

-

23

64/M

Maxillary sinus

+

-

NT

NT

-

+

-

-

+

80

NT

24

35/M

Lung

+

-

-

-

-

-

+

NT

-

60

-

25

40/F

Cevical

-

-

-

-

-

+

-

-

-

30

-

26

18/M

LN

+

-

+

-

-

+

NT

NT

NT

30

-

27

24/F

Ovarian

+

-

+

-

-

-

-

-

-

70

-

28

27/M

Mediastinum

+

-

+

-

-

+

-

-

+

100

-

  1. Note: LN, lymphoma node; -, negative; +, positive; NT, not tested; †, ‡, §, ¶: CD20 immunostaining in patient 3, 15, 19 and 20 were performed 2, 3, 4 and 2 times, respectively. All the results of CD20 immunostaining were negative.